Liam Ratcliffe
CIK 1547100 · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$16.46M
Companies
12
Total Filings
49
Lifetime Open-Market Net
-$6.25M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UPB | Director | — | $6.10 | — | $0 | 3 | 2026-06-11 |
| OKUR | Director | — | $4.20 | — | $0 | 2 | 2026-06-08 |
| IRON | Director | — | $67.99 | — | $0 | 3 | 2025-06-13 |
| Climb Bio, Inc. (ELYM) Delisted | Director | — | $5.11 | — | $0 | 4 | 2024-06-28 |
| ARVN | Director | 421,935 | $7.58 | $3.20M | -$10.41M | 11 | 2022-06-21 |
| PASG | Director | 2,069,430 | $5.81 | $12.02M | $10.00M | 4 | 2021-05-28 |
| Cogent Biosciences, Inc. (UMRX) Delisted | Director | 622,772 | — | — | $6.60M | 6 | 2019-06-18 |
| Aptinyx Inc. (APTX) Delisted | Director | 2,244,526 | $0.06 | $136.9K | $4.00M | 2 | 2019-04-02 |
| PDSB | Director | 1,182,434 | $1.05 | $1.24M | $0 | 1 | 2019-03-18 |
| EDGE | Director | — | $49.07 | — | $0 | 4 | 2018-08-15 |
| Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Director | 279,703 | $25.59 | $7.16M | $6.38M | 2 | 2018-05-21 |
| Aravive, Inc. (VSAR) Delisted | 10%+ Owner | 2,409,374 | — | — | -$22.81M | 1 | 2014-12-22 |
Recent Filings · Page 2 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-03 | — | Grant (A) | — | $0 | |
| 2022-06-21 | ARVN | Grant (A) | — | $0 | EDGAR |
| 2022-06-01 | Climb Bio, Inc. (ELYM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-16 | ARVN | Sell (S) | −355,705 | -$23.83M | EDGAR |
| 2021-11-15 | ARVN | Sell (S) | −134,310 | -$11.53M | EDGAR |
| 2021-11-09 | ARVN | Mixed | −153,656 | -$15.46M | EDGAR |
| 2021-08-11 | Climb Bio, Inc. (ELYM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-10 | ARVN | Grant (A) | — | $0 | EDGAR |
| 2021-05-28 | PASG | Grant (A) | — | $0 | EDGAR |
| 2020-12-21 | ARVN | Buy (P) | +142,857 | $10.00M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.